You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Born out of a project of the IUPAC's committee on Medicinal Chemistry and Drug Development, this reference addresses past and current strategies for successful drug analog development, extending the previously published volume by nine new analog classes and eight case studies. Like its precursor, this volume also contains a general section discussing universally applicable strategies for analog discovery and development. Spanning a wide range of therapeutic fields and chemical classes, the two volumes together constitute the first systematic approach to drug analog development. Of interest to virtually every researcher working in drug discovery and pharmaceutical chemistry.
The first authoritative overview of past and current strategies for successful drug development by analog generation, this unique resource spans all important drug classes and all major therapeutic fields, including histamine antagonists, ACE inhibitors, beta blockers, opioids, quinolone antibiotics, steroids and anticancer platinum compounds. Of the 19 analog classes presented in detail, 9 are described by the scientists who discoverd them. The book includes a table of the most successful drug analogs as based on the IMS ranking and compares them in terms of chemical structure, mode of action and patentability.
The publication of this volume completes the new edition of the sources and major analogues of all the Canterbury Tales prepared by members of the New Chaucer Society. This collection, the first to appear in over half a century, features such additions as a fresh interpretation of Chaucer's sources for the frame of the work, chapters on the sources of the General Prologue and Retractions, and modern English translations of all foreign language texts, with glosses for the Middle English. Chapters on the individual tales contain an updated survey of the present state of scholarship on their source materials. Several sources and analogues discovered during the past fifty years are found here to...
Many countries are currently exploring the option to dispose of highly radioactive solid wastes deep underground in purpose built, engineered repositories. A number of surface and shallow repositories for less radioactive wastes are already in operation. One of the challenges facing the nuclear industry is to demonstrate confidently that a repository will contain wastes for so long that any releases that might take place in the future will pose no significant health or environmental risk. One method for building confidence in the long-term future safety of a repository is to look at the physical and chemical processes which operate in natural and archaeological systems, and to draw appropriate parallels with the repository. For example, to understand why some uranium orebodies have remained isolated underground for billions of years. Such studies are called 'natural analogues'. This book investigates the concept of geological disposal and examines the wide range of natural analogues which have been studied. Lessons learnt from studies of archaeological and natural systems can be used to improve our capabilities for assessing the future safety of a radioactive waste repository.
Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and -- together with the previous volumes -- constitutes the first systematic approach to drug analogue development.
The molecular era ushered in the cloning of the growth hormone (GH) gene and the production of unlimited amounts of GH through recombinant technology. The continuing momentum of research from basic science to clinical evaluation has brought unprecedented advances to the understanding of GH biology for the clinical endocrinologist. Growth Hormone Related Diseases and Therapy: A Molecular and Physiological Perspective for the Clinician distills all the new information of relevance to the endocrinologist over the last 20 years by offering five sections: physiology, molecular genetics, GH deficiency, acromegaly and pharmacotherapy. The first section on physiology focuses on GH action. A review o...